Sort
25,944 grants matching “neurodegeneration”
Core E: Imaging
$419,642Tammie Lee Smith Benzinger · Washington University · P01 · FY2017 · AG
Calsenilin Interactions with PS2
$419,525Massachusetts General Hospital · R01 · FY2005 · AG
Calsenilin Interactions with PS2
$419,525Massachusetts General Hospital · R01 · FY2004 · AG
Calsenilin Interactions with PS2
$419,525Massachusetts General Hospital · R01 · FY2003 · AG
Pre-clinical testing of a novel gene therapy for pediatric neurodegenerative disease
$419,482Jonathan Rios · Ut Southwestern Medical Center · R21 · FY2024 · NS
Chromosome instability of glial cells in aging and Alzheimer's disease brain
$419,479Jan No Middle Name Vijg · Albert Einstein College Of Medicine · P01 · FY2020 · AG
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2009 · NS
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2007 · NS
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2008 · NS
Role of TFEB in Tauopathy
$419,383Hui Zheng · Baylor College Of Medicine · R01 · FY2015 · NS
In vivo multiplexed silencing of cis-elements in the brain
$419,375Chris Gregg · University Of Utah · R21 · FY2021 · AG
Pathological Implications of the tau-RNA Interaction
$419,375John Koren · University Of Florida · R21 · FY2025 · AG
Optimization and Preclinical Validation of QTE Therapy for Friedreich's Ataxia
$419,375Vijayendran Chandran · University Of Florida · R21 · FY2025 · TR
Can SARS-CoV-2 proteins accelerate Abeta pathology in fly and mouse models of AD?
$419,375Diego E Rincon-Limas · University Of Florida · R21 · FY2025 · AG
The Norepinephrine transporter as a therapeutic target for treatment of alpha-synuclein pathology in PD
$419,375Nikhil Urs · University Of Florida · R21 · FY2021 · NS
A Novel Neuroprotective Approach for Glaucoma
$419,255Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · EY
A Novel Neuroprotective Approach for Glaucoma
$419,255Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2020 · EY
A Novel Neuroprotective Approach for Glaucoma
$419,255Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2017 · EY
Neuroimaging and Molecular Markers of AD and Neurodegenerative Disease after Concussion
$419,208Jasmeet Pannu Hayes · Ohio State University · R01 · FY2019 · AG
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres
$419,181Yuri Persidsky · Temple Univ Of The Commonwealth · R01 · FY2011 · MH
Elucidating the impact of the Npc1nmf164 mutation in the postnatal cerebellar development of a mouse model of Niemann-Pick Type C disease
$419,088Ileana Soto Reyes · Rowan University · R15 · FY2018 · NS
The epigenome-metabolism nexus as a driver of circadian disruption in Alzheimer's disease
$419,005Vikki Marie Weake · Purdue University · R21 · FY2025 · AG
Abnormal Hyperphosphorylation of Tau
$418,877Khalid Iqbal · Institute For Basic Res In Dev Disabil · R01 · FY2008 · AG
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
$418,876Adam D Bachstetter · University Of Kentucky · R01 · FY2025 · NS
S-Nitrosylation of Matrix Metalloproteinases in AIDS
$418,800Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2007 · NS